Literature DB >> 11549218

Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque.

D C Javitt1, R W Lindsley.   

Abstract

RATIONALE: Prepulse inhibition (PPI) of the acoustic startle response (ASR) provides an index of neurophysiological dysfunction in schizophrenia and a method for analyzing underlying neurochemical mechanisms. In rodents, phencyclidine (PCP) and other N-methyl-D-aspartate receptor (NMDAR) antagonists induce schizophrenia-like PPI deficits. Similar effects have recently been observed in a New World monkey species, Cebus apella.
OBJECTIVES: The present study evaluates the degree to which similar effects are observed in an Old World monkey, M. fascicularis.
METHODS: An initial study evaluated effects of interstimulus interval on PPI amplitude and latency. A subsequent study evaluated effects of PCP (0.25 mg/kg i.m.) on PPI of the ASR.
RESULTS: Prepulses reduced both the amplitude and latency of the ASR. PCP treatment prevented both effects without affecting amplitude or latency of the ASR itself.
CONCLUSIONS: These results demonstrate that both amplitude reduction and latency facilitation are observed during PPI in the monkey and are disrupted by PCP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549218     DOI: 10.1007/s002130100758

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

1.  Developmental markers of psychiatric disorders as identified by sensorimotor gating.

Authors:  Susan B. Powell; Mark A. Geyer
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

2.  Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation.

Authors:  E Frecska; K D White; L E Luna
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

3.  Moderate-level prenatal alcohol exposure enhances acoustic startle magnitude and disrupts prepulse inhibition in adult rhesus monkeys.

Authors:  Mary L Schneider; Julie A Larson; Craig W Rypstat; Leslie M Resch; Andrew Roberts; Colleen F Moore
Journal:  Alcohol Clin Exp Res       Date:  2013-06-13       Impact factor: 3.455

Review 4.  Management of negative symptoms of schizophrenia.

Authors:  D C Javitt
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 5.  Preclinical models of antipsychotic drug action.

Authors:  José L Moreno; Javier González-Maeso
Journal:  Int J Neuropsychopharmacol       Date:  2013-06-10       Impact factor: 5.176

6.  Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.

Authors:  Gary S Linn; Shobhit S Negi; Scott V Gerum; Daniel C Javitt
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

7.  No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  Xiaoduo Fan; Emily Liu; Oliver Freudenreich; Paul Copeland; Douglas Hayden; Musie Ghebremichael; Bruce Cohen; Dost Ongur; Donald C Goff; David C Henderson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

8.  Interactions of the mGluR5 gene with breeding and maternal factors on startle and prepulse inhibition in mice.

Authors:  Suzanne A Brody; Mark A Geyer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition.

Authors:  L Elliot Hong; Ikwunga Wonodi; O Colin Stine; Braxton D Mitchell; Gunvant K Thaker
Journal:  Biol Psychiatry       Date:  2007-07-12       Impact factor: 13.382

10.  Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration.

Authors:  Yumi Shirai; Yuko Fujita; Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-08-31       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.